Emovi is a leading brand that offers a revolutionary knee clinical assessment platform called Knee Kinesiography. This platform, known as the KneeKG System, utilizes evidence-based care to evaluate knee functional deficiencies that are linked to patients' current symptoms or orthopedic disease progression. This innovative technology has been proven to greatly improve patient outcomes and satisfaction.

Integrating Knee Kinesiography into patient education has shown statistically significant and clinically superior improvements compared to the standard of care. In fact, patients treated with the KneeKG system experienced 42% less pain, 88% treatment adherence, and 84% patient satisfaction. Additionally, 63% of patients chose to delay surgery after one year, and 80% of those patients were able to postpone surgery after four years.

This groundbreaking clinical assessment platform provides high precision, confirming the appropriateness for surgery. It has been shown that 24% of patients who do not require surgery can be identified and removed from the surgical consultation queue. Emovi is dedicated to scientific excellence and has a wealth of literature to support Knee Kinesiography, with over 100 publications available.

The brand also boasts a distinguished clinical committee comprised of renowned experts in the field who have conducted extensive studies demonstrating the value of the KneeKG system. Choose Emovi and experience the benefits of their pioneering Knee Kinesiography platform for improved knee pain management and patient outcomes